Palonosetron' txoj kev tshem tawm hauv vivo suav nrog kev tso tawm los ntawm ob lub raum thiab kev koom tes ntawm ntau yam CYP enzymes. Cov kev tshawb fawb ntxiv hauv vitro tau pom tias Palonosetron tsis yog ib qho inhibitor ntawm CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2D6, CYP2E1, thiab CYP3A4/5 (CYP2C19 tsis tau kawm), thiab nws tsis ua rau muaj kev ua haujlwm ntawm CYP2A4 lossis CYP1A. Yog li ntawd, qhov ua tau ntawm cov tshuaj tseem ceeb hauv kev kho mob nrog Palonosetron yog tsawg heev.
Tom qab cov neeg ua haujlwm noj qab haus huv tau txhaj tshuaj 0.25 mg palonosetron thiab 20 mg dexamethasone tib lub sijhawm, tsis muaj kev cuam tshuam ntawm pharmacokinetic ntawm ob cov tshuaj. Lwm qhov kev sim tshuaj ntsuam xyuas ntawm cov tshuaj sib cuam tshuam ua rau cov neeg ua haujlwm noj qab haus huv tau pom tias 0.25 mg palonosetron tau txhaj tshuaj rau thawj hnub, thiab aprepitant (125 mg / 80 mg / 80 mg) tau noj qhov ncauj rau peb hnub sib law liag. Cov tshuaj pharmacokinetics ntawm lonosetron tsis hloov pauv ntau (AUC: tsis hloov, Cmax: 15% nce)
Cov neeg ua haujlwm noj qab haus huv tau txais ib koob tshuaj 0.75 mg ntawm palonosetron txhaj tshuaj, thiab metoclopramide tau noj hauv qhov ncauj (10 mg plaub zaug hauv ib hnub) thaum lub sijhawm ruaj khov. Tsis muaj qhov cuam tshuam pharmacokinetic tseem ceeb hauv txoj kev tshawb no.
Cov kev tshawb fawb soj ntsuam tau pom tias Palonosetron tuaj yeem siv tau zoo nrog corticosteroids, analgesics, antiemetics, antispasmodics thiab anticholinergic tshuaj.
Cov kev tshawb fawb nas qog nqaij hlav tau pom tias Palonosetron yuav tsis cuam tshuam rau kev tiv thaiv kabmob kheesxaws ntawm tsib cov tshuaj kws khomob tau kawm (cisplatin, cyclophosphamide, cytarabine, adriamycin thiab mitomycin C).

